about
PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?GLEPP1/protein-tyrosine phosphatase phi inhibitors block chemotaxis in vitro and in vivo and improve murine ulcerative colitisMolecular cloning and functional characterization of a novel mitogen-activated protein kinase phosphatase, MKP-4Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophilsMKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphataseMAP kinase phosphatase 3 (MKP3) interacts with and is phosphorylated by protein kinase CK2alphaCharacterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies.Activation of phospholipase C by G-protein beta gamma subunits in DDT1MF-2 cells.Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses.ASK1 promotes the contact hypersensitivity response through IL-17 production.Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1.Stimulation of phospholipase C-beta 2 by recombinant guanine-nucleotide-binding protein beta gamma dimers produced in a baculovirus/insect cell expression system. Requirement of gamma-subunit isoprenylation for stimulation of phospholipase C.A peptide corresponding to a potential polyphosphoinositide binding site of phospholipase C-beta 2 enhances its catalytic activity.BMP2 induction of actin cytoskeleton reorganization and cell migration requires PI3-kinase and Cdc42 activity.Functional whole-genome analysis identifies Polo-like kinase 2 and poliovirus receptor as essential for neuronal differentiation upstream of the negative regulator alphaB-crystallin.Involvement of phosphoinositide 3-kinase gamma, Rac, and PAK signaling in chemokine-induced macrophage migration.In vivo labeling of brain dopamine D2 receptors using the high-affinity specific D2 agonist [3H]CV 205-502.Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase.Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1.Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation.Isoform-selective phosphoinositide 3-kinase inhibitors induce apoptosis in chronic lymphocytic leukaemia cells.A Chemical Proteomics Approach to Phosphatidylinositol 3-Kinase Signaling in MacrophagesThe p110delta catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretionPI(3)Kγ has an important context-dependent role in neutrophil chemokinesisCatalytic Activation of the Phosphatase MKP-3 by ERK2 Mitogen-Activated Protein KinaseSubstrate Recognition Domains within Extracellular Signal-regulated Kinase Mediate Binding and Catalytic Activation of Mitogen-activated Protein Kinase Phosphatase-3Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease ModelsStimulation of phospholipase C by a mutationally activated G protein alpha 16 subunitAutoradiographic localization of dopamine D 1 and D 2 receptors in the brain of several mammalian speciesDopamine receptors in human brain: autoradiographic distribution of D2 sitesDopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiologyDopamine D1 and D2 receptors visualized in MPTP treated C57 mice by in vitro autoradiography: lack of evidence of receptor modifications in parkinsonian miceThe dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinasesCharacterization of putative polyphosphoinositide binding motifs from phospholipase C beta 2Identification and characterization of G protein-regulated phospholipase C in human myocardiumFuran-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gammaDiscovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton's Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases
P50
Q24296651-48968949-2FAB-47CF-B48E-18491353804FQ24313112-7706181A-ED6D-4711-B965-E7D32AB8D397Q24319662-046ECF93-FAB3-4265-8143-8858763286A8Q28249042-327199A4-52AF-4595-9A5F-775D06DD1579Q28278415-3E822F3E-6C35-4C6D-ACC9-231E94E8889AQ28593793-1AE5E63C-5941-4A80-9D65-33C57C528D14Q33659691-0B537686-4060-469A-9D80-620717052524Q34312527-B486DDD3-5274-40DA-9E36-F201853DEA1DQ34624894-EDF194D8-276E-49FB-AD36-0BA8F165BCA4Q37705602-0E816A38-1059-4732-B6D2-9298FC831671Q38342826-CDF16F0E-0671-461A-AA61-5BE1337B4CA5Q42068981-3C3AD736-6A8E-4B00-B400-3459ABA4B401Q42069485-3E597D40-9AF2-4CBA-B2DD-B0CAA1247D00Q42806559-AE08A9F6-DE6B-483F-8683-D1C723F8889EQ42836193-2CF7748F-BF84-4A3F-8E57-BC11630EE5AFQ45005871-B76F9984-5D26-475E-90A9-FF78FC44441EQ46525002-DA18560F-5FFB-409D-A038-704ECE1EE22CQ46586116-298B5D58-C352-408D-9D23-094CDCEA1E00Q46674143-A27C828D-7B9A-44FB-B8AE-A3D0EEA59BC2Q46941333-70ED5014-E639-42E3-8DB4-81032FF3704DQ51981008-AF67E5F4-011A-46C0-A7E8-3DD4A8C5DF0CQ54686785-7F3781B5-6A97-4186-8572-4AE8EC96733BQ56987082-6C3B5E7F-45C2-482D-A7D5-B968057C81AAQ57006226-7C569C4B-7890-4ADD-8E4A-FCA8DFFA9F45Q57006266-493E4998-FC68-4CF7-9BEC-B321837E9CFCQ60164205-509E75DD-1243-4A93-9E30-E26C66F8CB76Q61640748-D93D5FCB-5E64-414D-820A-8418AC6CAF01Q64113828-2580E787-52C7-4353-843B-258208CB55D6Q67588487-C63256C4-B4F1-4963-98F0-B7B2DFDD0651Q68413162-99D75D67-9742-40CF-9F65-4409FB26915DQ69295011-83C14FBE-CE15-4E4A-BD12-D88BE1772BBDQ69495326-0E9D3264-50E7-4520-AF7B-FB751DBBBDCDQ69552045-09EE7A87-EF02-4E4E-9488-57F91F6CFA3FQ71762901-92CA68C2-BC28-4F3F-9BCD-3A765EF79B5AQ72143207-3AE2D044-6D30-48EF-A691-6B27B2322CD1Q72999858-82B4E0B0-0E1C-48DE-85B3-A08747EAB3A0Q79764493-2FB66C49-1B90-4565-8753-417B95FE7605Q92334883-C4F88324-20AC-4862-9958-AD115FB7690E
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Montserrat Camps
@ast
Montserrat Camps
@en
Montserrat Camps
@es
Montserrat Camps
@nl
Montserrat Camps
@sl
type
label
Montserrat Camps
@ast
Montserrat Camps
@en
Montserrat Camps
@es
Montserrat Camps
@nl
Montserrat Camps
@sl
altLabel
Montse Camps
@en
prefLabel
Montserrat Camps
@ast
Montserrat Camps
@en
Montserrat Camps
@es
Montserrat Camps
@nl
Montserrat Camps
@sl
P106
P1153
7005716950
P21
P31
P496
0000-0002-9849-8657